TQB2210 Injection

TQB2210 · Chia Tai Tianqing Pharmaceutical Group

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB2210 Injection, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Tolerance of TQB2210 Injection [Phase 1]